The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.
How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Open accessAbstract
This review article summarizes recent research into the mechanisms as to how elevated levels of triglyceride (TG) and low levels of high- density- lipoprotein cholesterol (HDL-C) contribute to inflammation and atherosclerosis. Evidence supports the role of TG-rich lipoproteins in signaling mechanisms via apolipoproteins C-III and free fatty acids leading to activation of NFKβ, VCAM-1 and other inflammatory mediators which lead to fatty streak formation and advanced atherosclerosis. Moreover, the cholesterol content in TG-rich lipoproteins has been shown to predict CAD risk better than LDL-C. In addition to reverse cholesterol transport, HDL has many other cardioprotective effects which include regulating immune function. The "functionality" of HDL appears more important than the level of HDL-C. Insulin resistance and central obesity underlie the pathophysiology of elevated TG and low HDL-C in metabolic syndrome and type 2 diabetes. Lifestyle recommendations including exercise and weight loss remain first line therapy in ameliorating insulin resistance and the adverse signaling processes from elevated levels of TG-rich lipoproteins and low HDL-C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, TRLs have been implicated in pro-inflammatory signaling pathways, impairment of insulin sensitivity and upregulation of factors promoting thrombosis.22,23”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
Kawakami, A., Osaka, M., Aikawa, M., Uematsu, S., Akira, S., Libby, P., Shimokado, K., Sacks, F. M., & Yoshida, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.178426 · Cited by 76
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 2×
“%) with MS*** 4.3 25 0.03 AIM- HIGH [109] Stopped early after 3 years due to lack of benefit N Niacin extended release 1.5-2 g vs placebo; all received simvastatin 40– 80 mg+Ezetimibe 10 mg if needed 3414 men and women with CAD Fatal CVD, nonfatal MI, ischemic stroke, hospitalization for acute coronary syndrome, coron…”
BackgroundInfluentialType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Cited by
Sorted by citations
Items 201–221 of 221
Gender Considerations and Omega-3 Fatty Acids in Cardiovascular Disease
Adekar, S. P., Zanwar, A. A., Hegde, M. V., & Salunkhe, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-84200-9_3
Wu, P., Huang, Z., Ma, J., Zhu, B., Wang, M., Ma, A., Wang, X., Hai, R., Jia, S., Ma, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6611872/v1
Protective effect of high-density lipoprotein in infective endocarditis patients after valve surgery
Zhao, S., Li, Q., Liu, Z., Wang, B., Sun, Z., Wen, M., Lu, Y., Hu, Y., Chen, S., Han, J., et al. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101755
Owumi, S. E., Emmanuel, P. D., Chimezie, J., Joel, F. O., Idris, B., Babalola, J. O., & Owoeye, O. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04723-6
Montazeri Namin, S., Moradi, A., Tavolinejad, H., Vasheghani-Farahani, A., Jalali, A., Pashang, M., Sadeghian, S., Bagheri, J., Mansourian, S., Mehrani, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26702590
Zhang, D., Zheng, C., Zhu, T., Yang, F., & Zhou, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22602229
Li, J., Yu, Y., Sun, Y., Yu, B., Tan, X., Wang, B., Lu, Y., & Wang, N. (2023) · Figshare · doi:10.6084/m9.figshare.24329832
Wen, Q., Mao, X.-R., Wen, J., Yang, X.-J., Chen, J., Han, H.-K., Tang, X.-L., & Ma, Q.-H. (2024) · Figshare · doi:10.6084/m9.figshare.26753143
Zhang, D., Zheng, C., Zhu, T., Yang, F., & Zhou, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22602226
Exploring Uric Acid to HDL Ratio as a Long‐Term Biomarker for Diabetes Mellitus
Ahari, R. K., Khademi, R., Rahbardar, M. G., Shabani, N., Esmaily, H., Akbari, N., Alizadeh, R., Abedsaeidi, M., Soflaei, S. S., & Ghayour‐Mobarhan, M. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70157
Sayadi, M., Azami, P., Zibaeenezhad, M. J., Motazedian, N., Khademian, F., Hasanzadeh, M., Zibaeenejad, F., Mohammadi, S. S., Mousavinezhad, H., Daneshvar, Z., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343023
Identification of Important Risk Factors for Hypoproteinemia in Polycystic Ovaries Patients
Cheng, Z., & Lu, Y. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s577943
Li, N., Fei, C.-M., Tang, F., Lin, X.-S., Yang, B., Guo, J., Wu, L., Xia, Y., Zhang, C., & Xu, L. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01193-7
Li, S., Li, J., Xiang, F., Huang, Q., 鲜小华, Liu, J., & Xian, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-44940-4
Ølnes, Å. S., Teigen, M., Strøm, T. B., Arnesen, E., Rimbert, A., Eggen, A. E., & Bjune, K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344627
He, X., Liu, Z., Guo, Y.-F., Sun, P.-P., Zhao, R., & Zhong, X.-L. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07749-4
Huang, Y., & Yao, K. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02304-z
Kim, S. H., Kim, S., Lee, N. K., & Lee, S. W. (2026) · Healthcare · doi:10.3390/healthcare14131959
Dai, S., Luo, Y., Ghaffar, M. A., Wu, J., Zhu, J., Cao, Z., & Jiang, H. (2026) · Research Square · doi:10.21203/rs.3.rs-10640031/v1
Shomin, A. V., Serezhina, E. K., & Обрезан, А. Г. (2026) · Cardiosomatics · doi:10.17816/cs685972
Dyslipidemia and the Consumption of Mineral Waters: A Narrative Review
Vieira, D. C., Pinheiro, D., Pereira, C. D., Monteiro, R., & Martins, M. J. (2026) · Water · doi:10.3390/w18182350
Metadata
- Authors
- Welty, F. K.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Welty, Francine K.
- ORCID
- Welty, Francine K.
- Venue
- Current Cardiology Reports
- Published
- 2013-07-24
- Volume
- 15
- Issue
- 9
- Pages
- 400-400
- ISSN
- 1523-3782 (ISSN-L)
- 1534-3170
- PMC
- PMC4465984
- OpenAlex
- W2020040555
- Cited by
- 221
- References
- 120
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 26 · 2023: 34 · 2022: 21 · 2021: 23 · 2020: 16 · 2019: 19 · 2018: 15 · 2017: 12 · 2016: 7 · 2015: 3 · 2014: 4 · 2013: 2
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Cardiology Reports (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p50hl083813-05)
- National Heart, Lung, and Blood Institute (P50-HL083813)
- National Institute of Dental and Craniofacial Research (R01DE018184)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- triglyceride elevation, low HDL cholesterol, atherosclerosis, atherothrombosis, inflammation, triglyceride-rich lipoproteins, apolipoprotein C-III, free fatty acids, NF-κB, VCAM-1, fatty streak formation, coronary artery disease risk, reverse cholesterol transport, HDL function, immune function, insulin resistance, abdominal obesity, metabolic syndrome, type 2 diabetes, physical activity, weight loss
- MeSH terms
- Coronary Artery Disease, Humans, Inflammation, Cholesterol, HDL, Thrombosis, Triglycerides, Biomarkers, Inflammation Mediators, Metabolic Syndrome, Atherosclerosis, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
